Nephroprotective Effect of Coenzyme Q10 alone and in Combination with N-acetylcysteine in Diabetic Nephropathy

[1] Agarwal N, Sadhukhan P. Therapeutic Insights against Oxidative Stress Induced Diabetic Nephropathy: A Review. J Autoimmune Disord. 2015; 1: 1–17. AgarwalN SadhukhanP Therapeutic Insights against Oxidative Stress Induced Diabetic Nephropathy: A Review J Autoimmune Disord 2015 1 1 17 10.21767/2471-8153.100002 Search in Google Scholar

[2] Ahmad A, Mondello S, Di Paola R et al. Protective effect of apocynin, a NADPH-oxidase inhibitor, against contrast-induced nephropathy in the diabetic rats: A comparison with n-acetylcysteine. Eur J Pharmacol. 2012; 674: 397–406. AhmadA MondelloS Di PaolaR Protective effect of apocynin, a NADPH-oxidase inhibitor, against contrast-induced nephropathy in the diabetic rats: A comparison with n-acetylcysteine Eur J Pharmacol 2012 674 397 406 10.1016/j.ejphar.2011.10.04122094062 Search in Google Scholar

[3] Ahmadi A, Mazooji N, Roozbeh J, Mazloom Z, Hasanzade J. Effect of alpha-lipoic acid and vitamin E supplementation on oxidative stress, inflammation, and malnutrition in hemodialysis patients. Iran J Kidney Dis. 2013; 7: 461–467. AhmadiA MazoojiN RoozbehJ MazloomZ HasanzadeJ Effect of alpha-lipoic acid and vitamin E supplementation on oxidative stress, inflammation, and malnutrition in hemodialysis patients Iran J Kidney Dis 2013 7 461 467 Search in Google Scholar

[4] Ahmadvand H. Effects of coenzyme Q10 on hemoglobin A1C, serum urea and creatinine in alloxan-induced Type 1 diabetic rats. Iran J Pharmacol Ther. 2012; 11: 64–67. AhmadvandH Effects of coenzyme Q10 on hemoglobin A1C, serum urea and creatinine in alloxan-induced Type 1 diabetic rats Iran J Pharmacol Ther 2012 11 64 67 Search in Google Scholar

[5] Alam M, Rahman M. Mitochondrial dysfunction in obesity: Potential benefit and mechanism of co-enzyme Q10 supplementation in metabolic syndrome. J Diabetes Metab Disord. 2014; 13: 1–11. AlamM RahmanM Mitochondrial dysfunction in obesity: Potential benefit and mechanism of co-enzyme Q10 supplementation in metabolic syndrome J Diabetes Metab Disord 2014 13 1 11 10.1186/2251-6581-13-60405756724932457 Search in Google Scholar

[6] Algenstaedt P, Schaefer C, Biermann T, et al. Microvascular Alterations in Diabetic Mice Correlate with Level of Hyperglycemia. Diabetes. 2003; 52: 542–549. AlgenstaedtP SchaeferC BiermannT Microvascular Alterations in Diabetic Mice Correlate with Level of Hyperglycemia Diabetes 2003 52 542 549 10.2337/diabetes.52.2.54212540633 Search in Google Scholar

[7] Amin M, Asaad G, Abdel Salam R, El-Abhar H, Arbid M. Novel CoQ10 Antidiabetic Mechanisms Underlie Its Positive Effect: Modulation of Insulin and Adiponectine Receptors, Tyrosine Kinase, PI3K, Glucose Transporters, sRAGE and Visfatin in Insulin Resistant/Diabetic Rats. PLoS One. 2014; 9: e89169. AminM AsaadG Abdel SalamR El-AbharH ArbidM Novel CoQ10 Antidiabetic Mechanisms Underlie Its Positive Effect: Modulation of Insulin and Adiponectine Receptors, Tyrosine Kinase, PI3K, Glucose Transporters, sRAGE and Visfatin in Insulin Resistant/Diabetic Rats PLoS One 2014 9 e89169 10.1371/journal.pone.0089169393067524586567 Search in Google Scholar

[8] Ammon HP, Muller PH, Eggstein M, Wintermantel C, Aigner B, Safayhi H, et al. Increase in glucose consumption by acetylcysteine during hyperglycemic clamp. A study with healthy volunteers. Arzneimittelforsch. 1992; 42: 642–645. AmmonHP MullerPH EggsteinM WintermantelC AignerB SafayhiH Increase in glucose consumption by acetylcysteine during hyperglycemic clamp. A study with healthy volunteers Arzneimittelforsch 1992 42 642 645 Search in Google Scholar

[9] Anwar M, Abd El-Moniem M, Megahed H, EL-Toukhy S, Mohammed N, Youness E. Effect of Coenzyme Q10 Supplementation on Markers of Oxidative Stress in Streptozotocin Induced Diabetic Rats. Journal of Applied Pharmaceutical Science. 2014; 4: 9–15. AnwarM Abd El-MoniemM MegahedH EL-ToukhyS MohammedN YounessE Effect of Coenzyme Q10 Supplementation on Markers of Oxidative Stress in Streptozotocin Induced Diabetic Rats Journal of Applied Pharmaceutical Science 2014 4 9 15 10.7324/JAPS.2014.40602 Search in Google Scholar

[10] Ates O, Bilen H, Keles S, Alp H, Keles M, et al. Plasma coenzyme Q10 levels in type 2 diabetic patients with retinopathy. Int J Ophthalmol. 2013; 6: 675–679. AtesO BilenH KelesS AlpH KelesM Plasma coenzyme Q10 levels in type 2 diabetic patients with retinopathy Int J Ophthalmol 2013 6 675 679 Search in Google Scholar

[11] Badole SL, Bagul PP, Mahamuni SP et al. Oral L-glutamine increases active GLP-1 (7–36) amide secretion and improves glycemic control in streptozotocin-nicotinamide induced diabetic rats. ChemBiol Interact. 2013; 203: 530–541. BadoleSL BagulPP MahamuniSP Oral L-glutamine increases active GLP-1 (7–36) amide secretion and improves glycemic control in streptozotocin-nicotinamide induced diabetic rats ChemBiol Interact 2013 203 530 541 10.1016/j.cbi.2013.02.00623466488 Search in Google Scholar

[12] Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001; 414: 813–20. BrownleeM Biochemistry and molecular cell biology of diabetic complications Nature 2001 414 813 20 10.1038/414813a11742414 Search in Google Scholar

[13] Dabla PK. Renal function in diabetic nephropathy. World J Diabetes. 2010; 1: 48–56. DablaPK Renal function in diabetic nephropathy World J Diabetes 2010 1 48 56 10.4239/wjd.v1.i2.48308388221537427 Search in Google Scholar

[14] Garjani A, Andalib S, Biabani S, Soraya H, Doustar Y, et al. Combined atorvastatin and coenzyme Q10 improve the left ventricular function in isoproterenol-induced heart failure in rat. Eur J Pharmacol. 2011; 666: 135–141. GarjaniA AndalibS BiabaniS SorayaH DoustarY Combined atorvastatin and coenzyme Q10 improve the left ventricular function in isoproterenol-induced heart failure in rat Eur J Pharmacol 2011 666 135 141 10.1016/j.ejphar.2011.04.06121570962 Search in Google Scholar

[15] Geraldes P, Hiraoka-Yamamoto J, Matsumoto M, Clermont A, Leitges M, et al. Activation of PKC-delta and SHP-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathy. Nat Med. 2009; 15: 1298–1306. GeraldesP Hiraoka-YamamotoJ MatsumotoM ClermontA LeitgesM Activation of PKC-delta and SHP-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathy Nat Med 2009 15 1298 1306 10.1038/nm.2052329090619881493 Search in Google Scholar

[16] Ghasemi A, Khalifi S, Jedi S. Streptozotocin-nicotinamide induced rat model of type 2 diabetes. Acta Physiol Hung. 2014; 101: 408–420. GhasemiA KhalifiS JediS Streptozotocin-nicotinamide induced rat model of type 2 diabetes Acta Physiol Hung 2014 101 408 420 10.1556/APhysiol.101.2014.4.225532953 Search in Google Scholar

[17] Haber CA, Lam TK, Yu Z et al. N-acetylcysteine and taurine prevent hyperglycemia-induced insulin resistance in vivo: possible role of oxidative stress. Am J Physiol Endocrinol Metab. 2003; 285: E744–E753. HaberCA LamTK YuZ N-acetylcysteine and taurine prevent hyperglycemia-induced insulin resistance in vivo: possible role of oxidative stress Am J Physiol Endocrinol Metab 2003 285 E744 E753 10.1152/ajpendo.00355.200212799318 Search in Google Scholar

[18] Haraldsson B, Sörensson J. Why do we not all have proteinuria? An update of our current understanding of the glomerular barrier. News Physiol Sci. 2004; 19: 7–10. HaraldssonB SörenssonJ Why do we not all have proteinuria? An update of our current understanding of the glomerular barrier News Physiol Sci 2004 19 7 10 10.1152/nips.01461.200314739395 Search in Google Scholar

[19] Hasegawa G, Yamamoto Y, Zhi J, Tanino Y, Yamasaki M, et al. Daily profile of plasma %CoQ10 level, a biomarker of oxidative stress, in patients with diabetes manifesting postprandial hyperglycaemia. Acta Diabetol. 2005; 42: 179–181. HasegawaG YamamotoY ZhiJ TaninoY YamasakiM Daily profile of plasma %CoQ10 level, a biomarker of oxidative stress, in patients with diabetes manifesting postprandial hyperglycaemia Acta Diabetol 2005 42 179 181 10.1007/s00592-005-0199-616382305 Search in Google Scholar

[20] Ho E, Chen G, Bray TM. Supplementation of N-acetylcysteine inhibits NF-kappaB activation and protects against alloxan-induced diabetes in CD-1 mice. FASEB J. 1999; 13: 1845–1854. HoE ChenG BrayTM Supplementation of N-acetylcysteine inhibits NF-kappaB activation and protects against alloxan-induced diabetes in CD-1 mice FASEB J 1999 13 1845 1854 10.1096/fasebj.13.13.1845 Search in Google Scholar

[21] Hodgson JM, Watts GF, Playford DA, Burke V, Croft KD. Coenzyme Q10 improves blood pressure and glycaemic control: A controlled trial in subjects with type 2 diabetes. Eur J Clin Nutr. 2002; 56: 1137–1142. HodgsonJM WattsGF PlayfordDA BurkeV CroftKD Coenzyme Q10 improves blood pressure and glycaemic control: A controlled trial in subjects with type 2 diabetes Eur J Clin Nutr 2002 56 1137 1142 10.1038/sj.ejcn.160146412428181 Search in Google Scholar

[22] Idris I, Gray S, Donnelly R. Protein kinase C activation: isozyme-specific effects on metabolism and cardiovascular complications in diabetes. Diabetologia. 2001; 44: 659–673. IdrisI GrayS DonnellyR Protein kinase C activation: isozyme-specific effects on metabolism and cardiovascular complications in diabetes Diabetologia 2001 44 659 673 10.1007/s00125005167511440359 Search in Google Scholar

[23] Jemai H, El Feki A, Sayadi S. Antidiabetic and antioxidant effects of hydroxytyrosol and oleuropein from olive leaves in alloxan-diabetic rats. J Agric Food Chem. 2009; 57: 8798–8804. JemaiH El FekiA SayadiS Antidiabetic and antioxidant effects of hydroxytyrosol and oleuropein from olive leaves in alloxan-diabetic rats J Agric Food Chem 2009 57 8798 8804 10.1021/jf901280r19725535 Search in Google Scholar

[24] Kisic B, Miric D, Dragojevic I, Rasic J, Popovic L. Role of Myeloperoxidase in Patients with Chronic Kidney Disease. Oxid Med Cell Longev. 2016; 1–10. KisicB MiricD DragojevicI RasicJ PopovicL Role of Myeloperoxidase in Patients with Chronic Kidney Disease Oxid Med Cell Longev 2016 1 10 10.1155/2016/1069743483415127127544 Search in Google Scholar

[25] Kohei KA. Pathophysiology of type 2 diabetes and its treatment policy. JMAJ. 2010; 53: 41–46. KoheiKA Pathophysiology of type 2 diabetes and its treatment policy JMAJ 2010 53 41 46 Search in Google Scholar

[26] Krhač M, Lovrenčić MV. Update on biomarkers of glycemic control. World J Diabetes. 2019; 10: 1–15. KrhačM LovrenčićMV Update on biomarkers of glycemic control World J Diabetes 2019 10 1 15 10.4239/wjd.v10.i1.1634765430697366 Search in Google Scholar

[27] Lee ES, Kim HM, Kang JS, Lee EY, et al. Oleanolic acid and N-acetylcysteine ameliorate diabetic nephropathy through reduction of oxidative stress and endoplasmic reticulum stress in a type 2 diabetic rat model. Nephrol Dial Transplant. 2016; 3: 391–400. LeeES KimHM KangJS LeeEY Oleanolic acid and N-acetylcysteine ameliorate diabetic nephropathy through reduction of oxidative stress and endoplasmic reticulum stress in a type 2 diabetic rat model Nephrol Dial Transplant 2016 3 391 400 10.1093/ndt/gfv37726567248 Search in Google Scholar

[28] Mahajan MS, Gulecha VS, Upaganlawar AB, Upasani CD. Antioxidant Defense in Diabetic Nephropathy In: Uddin S & Upaganlawar AB: Oxidative Stress and Antioxidant Defense: Biomedical value in Health and Diseases, 1st ed. New York: Nova; 2019. MahajanMS GulechaVS UpaganlawarAB UpasaniCD Antioxidant Defense in Diabetic Nephropathy In: UddinS UpaganlawarAB Oxidative Stress and Antioxidant Defense: Biomedical value in Health and Diseases 1st ed. New York Nova 2019 Search in Google Scholar

[29] Maheshwari R, Balaraman R, Sen AK, Shukla D, Seth A. Effect of concomitant administration of coenzyme Q10 with sitagliptin on experimentally induced diabetic nephropathy in rats. Renal Failure. 2017; 39: 130–139. MaheshwariR BalaramanR SenAK ShuklaD SethA Effect of concomitant administration of coenzyme Q10 with sitagliptin on experimentally induced diabetic nephropathy in rats Renal Failure 2017 39 130 139 10.1080/0886022X.2016.1254659601450627841100 Search in Google Scholar

[30] Maheshwari RA, Balaraman R, Sen AK, Seth AK. Effect of coenzyme Q10 alone and its combination with metformin on streptozotocin-nicotinamide-induced diabetic nephropathy in rats. Indian J Pharmacol. 2014; 46: 627–32. MaheshwariRA BalaramanR SenAK SethAK Effect of coenzyme Q10 alone and its combination with metformin on streptozotocin-nicotinamide-induced diabetic nephropathy in rats Indian J Pharmacol 2014 46 627 32 10.4103/0253-7613.144924426407925538335 Search in Google Scholar

[31] Maitra A. The Endocrine System. in: Kumar V, Abbas A, Fausto N, Aster J. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Philadelphia: Elsevier Saunders; 2015. MaitraA The Endocrine System in: KumarV AbbasA FaustoN AsterJ Robbins and Cotran Pathologic Basis of Disease 9th ed. Philadelphia Elsevier Saunders 2015 10.1016/B978-1-4377-0792-2.50029-8 Search in Google Scholar

[32] Masharani, U. Diabetes Mellitus and hypoglycemia. In: McPhee SJ, Papadakis MA, Tierney LM. Current medical diagnosis and treatment, 47th ed. New York: McGraw-Hill; 2008. MasharaniU Diabetes Mellitus and hypoglycemia In: McPheeSJ PapadakisMA TierneyLM Current medical diagnosis and treatment 47th ed. New York McGraw-Hill 2008 Search in Google Scholar

[33] Mezawa M, Takemoto M, Onishi S, Ishibashi R, Ishikawa T, Yamaga, M, et al. The reduced form of coenzyme Q10 improves glycemic control in patients with type 2 diabetes: an open label pilot study. Biofactors. 2012; 38: 416–421. MezawaM TakemotoM OnishiS IshibashiR IshikawaT YamagaM The reduced form of coenzyme Q10 improves glycemic control in patients with type 2 diabetes: an open label pilot study Biofactors 2012 38 416 421 10.1002/biof.103822887051 Search in Google Scholar

[34] Midaoui A, Ismael M, Lu H, Fantus I, de Champlain J, Couture R. Comparative effects of N-acetyl-L-cysteineand ramipril on arterial hypertension, insulin resistance, andoxidative stress in chronically glucose-fed rats. Can J Physiol Pharmacol. 2008; 86: 752–60 MidaouiA IsmaelM LuH FantusI de ChamplainJ CoutureR Comparative effects of N-acetyl-L-cysteineand ramipril on arterial hypertension, insulin resistance, andoxidative stress in chronically glucose-fed rats Can J Physiol Pharmacol 2008 86 752 60 10.1139/Y08-09019011670 Search in Google Scholar

[35] Mogensen CE. Microalbuminuria, blood pressure and diabetic renal disease. Origin and development of ideas. Diabetologia. 1999; 42: 263–285. MogensenCE Microalbuminuria, blood pressure and diabetic renal disease. Origin and development of ideas Diabetologia 1999 42 263 285 10.1007/s00125005115110096778 Search in Google Scholar

[36] Mogensen CE, Christensen CK, Vittinghus E. The stages in diabetic renal disease. With emphasis on the stage of incipient diabetic nephropathy. Diabetes. 1983; 32: 64–78. MogensenCE ChristensenCK VittinghusE The stages in diabetic renal disease. With emphasis on the stage of incipient diabetic nephropathy Diabetes 1983 32 64 78 10.2337/diab.32.2.S646400670 Search in Google Scholar

[37] Mora-Fernández C, Domínguez-Pimentel V, de Fuentes MM, et al. Diabetic kidney disease: from physiology to therapeutics. J Physiol. 2014; 592: 3997–4012. Mora-FernándezC Domínguez-PimentelV de FuentesMM Diabetic kidney disease: from physiology to therapeutics J Physiol 2014 592 3997 4012 10.1113/jphysiol.2014.272328419801024907306 Search in Google Scholar

[38] Odetti P, Pesce C, Traverso N, Menini S, Maineri EP, et al. Comparative trial of N-acetyl-cysteine, taurine, and oxerutin on skin and kidney damage in long-term experimental diabetes. Diabetes. 2003; 52: 499–505. OdettiP PesceC TraversoN MeniniS MaineriEP Comparative trial of N-acetyl-cysteine, taurine, and oxerutin on skin and kidney damage in long-term experimental diabetes Diabetes 2003 52 499 505 10.2337/diabetes.52.2.499 Search in Google Scholar

[39] Oktem F, Ozguner F, Yilmaz HR, et al. Melatonin reduces urinary excretion of N-acetyl-beta–D-glucosaminidase, albumin and renal oxidative markers in diabetic rats. Clin Exp Pharmacol Physiol. 2006; 33: 95–101. OktemF OzgunerF YilmazHR Melatonin reduces urinary excretion of N-acetyl-beta–D-glucosaminidase, albumin and renal oxidative markers in diabetic rats Clin Exp Pharmacol Physiol 2006 33 95 101 10.1111/j.1440-1681.2006.04330.x Search in Google Scholar

[40] Pal PB, Sinha K, Sil PC. Mangiferin attenuates diabetic nephropathy by inhibiting oxidative stress mediated signaling cascade, TNFα related and mitochondrial dependent apoptotic pathways in streptozotocin-induced diabetic rats. PLoS One. 2014; 9: e107220. PalPB SinhaK SilPC Mangiferin attenuates diabetic nephropathy by inhibiting oxidative stress mediated signaling cascade, TNFα related and mitochondrial dependent apoptotic pathways in streptozotocin-induced diabetic rats PLoS One 2014 9 e107220 10.1371/journal.pone.0107220 Search in Google Scholar

[41] Prabhakar SS. Role of nitric oxide in diabetic nephropathy. Semin Nephrol. 2004; 24: 333–344. PrabhakarSS Role of nitric oxide in diabetic nephropathy Semin Nephrol 2004 24 333 344 10.1016/j.semnephrol.2004.04.005 Search in Google Scholar

[42] Rajkumar L, Govindarajulu P. Increased degradation of dermal collagen in diabetic rats. Indian J Exp Bio. 1991; 29: 1081–1083. RajkumarL GovindarajuluP Increased degradation of dermal collagen in diabetic rats Indian J Exp Bio 1991 29 1081 1083 Search in Google Scholar

[43] Rajkumar V, Ragatzki P, Sima A, Levy J. Enhanced platelet aggregation, high homocysteine level, and microvascular disease in diabetic muscle infaractions. Endocrine. 1999; 11: 57–60. RajkumarV RagatzkiP SimaA LevyJ Enhanced platelet aggregation, high homocysteine level, and microvascular disease in diabetic muscle infaractions Endocrine 1999 11 57 60 10.1385/ENDO:11:1:57 Search in Google Scholar

[44] Rosenfeldt FL, Haas SJ, Krum H. Coenzyme Q10 in the treatment of hypertension: a meta-analysis of the clinical trials. J Hum Hypertens. 2007; 21: 297–306. RosenfeldtFL HaasSJ KrumH Coenzyme Q10 in the treatment of hypertension: a meta-analysis of the clinical trials J Hum Hypertens 2007 21 297 306 10.1038/sj.jhh.100213817287847 Search in Google Scholar

[45] Rovira-Llopis S, Rocha M, Victor M et al. Is myeloperoxidase a key component in the ROS-induced vascular damage related to nephropathy in type 2 diabetes?” ARS. 2013; 19: 1452–1458. Rovira-LlopisS RochaM VictorM Is myeloperoxidase a key component in the ROS-induced vascular damage related to nephropathy in type 2 diabetes?” ARS 2013 19 1452 1458 10.1089/ars.2013.5307379745023521574 Search in Google Scholar

[46] Roy S, Trudeau K, Roy S, Behl Y, Dhar S, Chronopoulos A. New insights into hyperglycemia-induced molecular changes in microvascular cells. J Dent Res. 2010; 89: 116–128. RoyS TrudeauK RoyS BehlY DharS ChronopoulosA New insights into hyperglycemia-induced molecular changes in microvascular cells J Dent Res 2010 89 116 128 10.1177/002203450935576520042738 Search in Google Scholar

[47] Schena FP and Gesualdo L. Pathogenetic mechanisms of diabetic nephropathy. J. Am. Soc. Nephrol. 2010; 16: 30–33. SchenaFP GesualdoL Pathogenetic mechanisms of diabetic nephropathy J. Am. Soc. Nephrol 2010 16 30 33 10.1681/ASN.200411097015938030 Search in Google Scholar

[48] Shimizu MH, Coimbra TM, de Araujo M et al. N-acetylcysteine attenuates the progression of chronic renal failure. Kidney Int. 2005; 68: 2208–2217. ShimizuMH CoimbraTM de AraujoM N-acetylcysteine attenuates the progression of chronic renal failure Kidney Int 2005 68 2208 2217 10.1111/j.1523-1755.2005.00677.x16221220 Search in Google Scholar

[49] Sourris K, Harcourt B, Tang P, Morley A, Huynh K, et al. Ubiquinone (coenzyme Q10) prevents renal mitochondrial dysfunction in an experimental model of type 2 diabetes. Free Radic Biol Med. 2012; 52: 716–723. SourrisK HarcourtB TangP MorleyA HuynhK Ubiquinone (coenzyme Q10) prevents renal mitochondrial dysfunction in an experimental model of type 2 diabetes Free Radic Biol Med 2012 52 716 723 10.1016/j.freeradbiomed.2011.11.01722172526 Search in Google Scholar

[50] Stamler JS, Singel DJ, Loscalzo J. Biochemistry of nitric oxide and its redox-activated forms. Science. 1992; 258: 1898–902. StamlerJS SingelDJ LoscalzoJ Biochemistry of nitric oxide and its redox-activated forms Science 1992 258 1898 902 10.1126/science.12819281281928 Search in Google Scholar

[51] Teoh SL, Abdulatiff A, Das S. Histological changes in the kidneys of experimental diabetic rats fed with Momordicalcharantia (bitter gourd) extract. Rom J MorpholEmbryol. 2010; 51: 91–5. TeohSL AbdulatiffA DasS Histological changes in the kidneys of experimental diabetic rats fed with Momordicalcharantia (bitter gourd) extract Rom J MorpholEmbryol 2010 51 91 5 Search in Google Scholar

[52] Vasavada N and Agarwal R. Role of Oxidative Stress in Diabetic Nephropathy. Adv Chronic Kidney Dis. 2005; 12: 146–154. VasavadaN AgarwalR Role of Oxidative Stress in Diabetic Nephropathy Adv Chronic Kidney Dis 2005 12 146 154 10.1053/j.ackd.2005.01.00115822050 Search in Google Scholar

[53] Vora JP and Ibrahim HAA. Clinical manifestations and natural history of diabetic nephropathy. In: Johnson R and Feehally J: Comprehensive clinical nephrology, 2nd ed. Edinburgh: Mosby; 2003. VoraJP IbrahimHAA Clinical manifestations and natural history of diabetic nephropathy In: JohnsonR FeehallyJ Comprehensive clinical nephrology 2nd ed. Edinburgh Mosby 2003 Search in Google Scholar

[54] Zhang X, Shi Z, Liu Q, Quan H, Cheng X. Effects of coenzyme Q10 intervention on diabetic kidney disease. Medicine. 2019; 98: 1–18. ZhangX ShiZ LiuQ QuanH ChengX Effects of coenzyme Q10 intervention on diabetic kidney disease Medicine 2019 98 1 18 10.1097/MD.0000000000015850658747331192915 Search in Google Scholar